Key result
Admission hyponatraemia (<135 mEq/L) in patients with acute heart failure was associated with a higher risk of 6-month mortality and hospitalization (OR 5.9; 95% CI 2.8-12.0; P<0.001).
Why the study?
Hyponatraemia is common in heart failure, but its prognostic value for worsening heart failure has not been well defined.
Does admission hyponatraemia predict mortality and rehospitalization in patients with acute heart failure?
Cohort (n=134)
Does admission hyponatraemia predict mortality and rehospitalization in patients with acute heart failure?
Odds Ratio: 5.9 (95% CI 2.8–12)
p-value: p=<0.001
Admission hyponatraemia is a strong independent predictor of 6-month mortality and rehospitalization in patients with acute heart failure.
Admission hyponatremia may identify higher-risk acute HF patients; leaves open whether correction improves outcomes.
AIMS: Heart failure remained consistent as one of the biggest cardiovascular problems in Indonesia. Hyponatraemia is a common electrolyte disorder among patients presented with heart failure; however, the prognostic value for worsening heart failure has not been well defined. METHODS AND RESULTS: We studied 134 patients admitted with acute heart failure and investigated the relationship between admission serum sodium and the composite clinical outcomes of all-cause mortality and hospitalization ambispectively with a follow-up duration of 6 months. We also try to look for low sodium-level impacts in several conditions. Among 134 patients, 84 patients presented with low sodium during admission, defined as a serum sodium level of <135 mEq/L, and it was associated with higher composite clinical outcome risk [odds ratio (OR), 5.9; 95% confidence interval (CI), 2.8-12.0; P < 0.001]. Moreover, hyponatraemia impacts on composite endpoints were driven by both parameters; it was independently associated with mortality (OR, 3.1; 95% CI, 1.4-6.8; P = 0.003) and rehospitalization (OR, 5.3; 95% CI, 2.4-11.7; P < 0.001). This result remained consistent in most subgroups. CONCLUSIONS: On-admission hyponatraemia is a predictor for 6 month mortality and rehospitalization. Further work is needed to determine if correction of hyponatraemia translates into clinical benefit.
No takes yet. Share an insight, caveat, or question.
Sarastri et al. (2023) conducted a cohort in Acute heart failure (n=134). Admission hyponatraemia (serum sodium <135 mEq/L) vs. Normal serum sodium was evaluated on Composite clinical outcomes of all-cause mortality and hospitalization (OR 5.9, 95% CI 2.8-12.0, p=<0.001). Admission hyponatraemia (<135 mEq/L) in patients with acute heart failure was associated with a higher risk of 6-month mortality and hospitalization (OR 5.9; 95% CI 2.8-12.0; P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: